|
  |
|
|
 |
 |
| |
    |
|
 
| The wide range of issues covered by AESGP are reflected in many publications. In their totality they constitute an important knowledge base. All AESGP publications are available from the AESGP offices. Those available on-line are linked from this page. . |
| |
|
|
"The Legal and Regulatory Framework for Herbal Medicines in Europe"
April 2010
To order the study, click here.
|
"The Economic and Legal Framework for Non-Prescription Medicines"
June 2010
To order the study, click here.
|
 |
 |
"The Regulatory Framework for Food Supplements in Europe"
June 2007
To order the study, click here. |
|
| |
|
- For the AESGP Annual Reports and the publication 40 Years Working For Self-Medication, see the heading "About Us".
|
| |
- Smart Regulation 2015 - The Future Regulation of Self-Care, June 2008
To make the AESGP vision a reality there is a need for making adjustments in the legal and regulatory environment so that the future self-care market in the European Union is open and free: the market is open so that new products can be launched without untimely delays and free in the sense that the communication on self-care products is not unnecessarily restricted.
The booklet sets out AESGP's suggestions for the future regulation of self-care.
|
|
|
- The Economic and Public Health Value of Self-Medication,
June 2004
Responsible self-medication considerably reduces the expenses of social security systems and healthcare costs for national economies. Based on a detailed analysis of seven European countries, total annual savings resulting from a move of 5% of prescribed medications to self-medication exceed 16 billion euros. This demonstrates that self-medication makes a significant contribution to relieving the financial burden of the European healthcare systems.
At the same time, the move of medicines from prescription to non-prescription status and the availability of a growing range of non-prescription medicines make an important contribution to public health. Case studies on vaginal mycosis, smoking cessation and heart disease prevention demonstrate how innovative non-prescription medicines may improve treatment as well as prevention of illness.
|
|
and
|
 |
|
Study carried out on behalf of the European Commission by AESGP, 1998
|
 |
|
Consumers are willing and able to take more responsibility for their own health and by so doing, a significant amount of resources could be freed up to be utilised in more pressing areas than patients receiving consultations and prescriptions for minor ailments. |
- Improving the Visibility of Self-Medication in Pharmacies, May 1998
|
- The Visibility of Self-Medication Products in the Changing Pharmacy Environment, June 1997
|
- The Value of the same Trademark for medicines with a different Legal Status, May 1996
|
- CP/PGEU/AESGP Joint Symposium, Brussels, Belgium, January 1996
|
- The Individual and Health Care: Added Value through Self-Medication, 1994
|
- Self-medication in Central & Eastern Europe, 1993
|
- Self-Medication and the Pharmacist, 1993
|
|
|
|
|
|
|
|
